Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2019 Filed Mar 1, 2019 00:21 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
GrantRestricted Stock Units · Derivative | 18,029 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-005313 · doc4.xml · derivative · entry 13 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,197 Underlying: Common Stock · 18,029 shares Expires not disclosed F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F9 · derivative.exercise_date: On February 26, 2019, Mr. El-Hibri was granted 18,029 restricted stock units vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date. F9 · derivative.expiration_date: On February 26, 2019, Mr. El-Hibri was granted 18,029 restricted stock units vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:21 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 6,430 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-005313 · doc4.xml · derivative · entry 12 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,168 Underlying: Common Stock · 6,430 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F8 · derivative.exercise_date: On February 27, 2018, Mr. El-Hibri was granted 19,288 restricted stock units vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date. F8 · derivative.expiration_date: On February 27, 2018, Mr. El-Hibri was granted 19,288 restricted stock units vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:21 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Tax withholdingCommon Stock | 1,566 | $61.01 | $95,541.66 |
DisclosureSEC source: 0000899243-19-005313 · doc4.xml · nonDerivative · entry 3 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,483,170 Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:21 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionCommon Stock | 6,430 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-005313 · doc4.xml · nonDerivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,484,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:21 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 10,369 | $59.65 | $618,510.85 |
DisclosureSEC source: 0000899243-19-005313 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,478,306 F1 · kind: All sales listed on this Form 4 were made by Mr. El-Hibri pursuant to a trading plan adopted on June 6, 2018 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934 (the "Exchange Act"). F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.40 to $61.21. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:06 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 20,321 | $61.01 Strike: $61.01 | $1,239,784.21 |
DisclosureSEC source: 0001567619-19-005674 · doc1.xml · derivative · entry 3 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,321 Underlying: Common Stock · 20,321 shares Expires 2026-02-25 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:06 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
GrantCommon Stock | 5,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005674 · doc1.xml · nonDerivative · entry 2 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,696 F3 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:06 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
GrantCommon Stock | 5,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005674 · doc1.xml · nonDerivative · entry 1 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,615 F1 · security: Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated. F2 · shares: These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:31 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 20,321 | $61.01 Strike: $61.01 | $1,239,784.21 |
DisclosureSEC source: 0001567619-19-005677 · doc1.xml · derivative · entry 4 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,321 Underlying: Common Stock · 20,321 shares Expires 2016-02-25 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:31 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
GrantCommon Stock | 5,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005677 · doc1.xml · nonDerivative · entry 3 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,782 F3 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:31 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
GrantCommon Stock | 5,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005677 · doc1.xml · nonDerivative · entry 2 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,701 F2 · shares: These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:31 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
Tax withholdingCommon Stock | 534 | $61.01 | $32,579.34 |
DisclosureSEC source: 0001567619-19-005677 · doc1.xml · nonDerivative · entry 1 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,620 F1 · security: Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:35 UTC |
Kramer RobertPresident and COO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 47,197 | $61.01 Strike: $61.01 | $2,879,488.97 |
DisclosureSEC source: 0001567619-19-005678 · doc1.xml · derivative · entry 6 Kramer Robert · CIK 0001380956 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,197 Underlying: Common Stock · 47,197 shares Expires 2026-02-25 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:35 UTC |
Kramer RobertPresident and COO
|
GrantCommon Stock | 11,801 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005678 · doc1.xml · nonDerivative · entry 3 Kramer Robert · CIK 0001380956 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,209 F3 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:35 UTC |
Kramer RobertPresident and COO
|
GrantCommon Stock | 11,801 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005678 · doc1.xml · nonDerivative · entry 2 Kramer Robert · CIK 0001380956 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,408 F2 · shares: These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:35 UTC |
Kramer RobertPresident and COO
|
Tax withholdingCommon Stock | 565 | $61.01 | $34,470.65 |
DisclosureSEC source: 0001567619-19-005678 · doc1.xml · nonDerivative · entry 1 Kramer Robert · CIK 0001380956 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,607 F1 · security: Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:38 UTC |
Havey AdamEVP, Business Operations
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 20,321 | $61.01 Strike: $61.01 | $1,239,784.21 |
DisclosureSEC source: 0001567619-19-005679 · doc1.xml · derivative · entry 6 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,321 Underlying: Common Stock · 20,321 shares Expires 2026-02-25 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:38 UTC |
Havey AdamEVP, Business Operations
|
GrantCommon Stock | 5,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005679 · doc1.xml · nonDerivative · entry 3 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,934 F3 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:38 UTC |
Havey AdamEVP, Business Operations
|
GrantCommon Stock | 5,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005679 · doc1.xml · nonDerivative · entry 2 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,853 F2 · shares: These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:38 UTC |
Havey AdamEVP, Business Operations
|
Tax withholdingCommon Stock | 481 | $61.01 | $29,345.81 |
DisclosureSEC source: 0001567619-19-005679 · doc1.xml · nonDerivative · entry 1 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,772 F1 · security: Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 00:03 UTC |
Abdun-Nabi DanielDirector · CEO
|
Tax withholdingCommon Stock | 1,714 | $61.01 | $104,571.14 |
DisclosureSEC source: 0001567619-19-005673 · doc1.xml · nonDerivative · entry 1 Abdun-Nabi Daniel · CIK 0001380187 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,853 F1 · security: Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated. Read SEC document |
| November 27, 2018 Filed Nov 28, 2018 22:48 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 20,832 | $69.59 | $1,449,698.88 |
DisclosureSEC source: 0000899243-18-029754 · doc4.xml · nonDerivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,407,670 F1 · kind: All sales listed on this Form 4 were made by Mr. El-Hibri pursuant to a trading plan adopted on June 6, 2018 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934 (the "Exchange Act"). F3 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.31 to $70.32. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 16:41 UTC |
Bailey SueDirector
|
Exercise / conversionStock Option (Right to buy) · Derivative | 3,158 | $0.00 Strike: $13.37 | $0.00 |
DisclosureSEC source: 0001567619-18-007116 · doc1.xml · derivative · entry 12 Bailey Sue · CIK 0001403769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,158 shares Expires 2019-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. F3 · derivative.exercise_date: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 16:41 UTC |
Bailey SueDirector
|
Exercise / conversionStock Option (Right to buy) · Derivative | 4,736 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0001567619-18-007116 · doc1.xml · derivative · entry 11 Bailey Sue · CIK 0001403769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,736 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. F3 · derivative.exercise_date: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 16:41 UTC |
Bailey SueDirector
|
Exercise / conversionStock Option (Right to buy) · Derivative | 1,579 | $0.00 Strike: $20.08 | $0.00 |
DisclosureSEC source: 0001567619-18-007116 · doc1.xml · derivative · entry 10 Bailey Sue · CIK 0001403769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,579 shares Expires 2021-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. F3 · derivative.exercise_date: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 16:41 UTC |
Bailey SueDirector
|
Exercise / conversionStock Option (Right to buy) · Derivative | 8,244 | $0.00 Strike: $18.64 | $0.00 |
DisclosureSEC source: 0001567619-18-007116 · doc1.xml · derivative · entry 9 Bailey Sue · CIK 0001403769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,244 shares Expires 2021-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. F3 · derivative.exercise_date: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 16:41 UTC |
Bailey SueDirector
|
SaleCommon Stock | 3,158 | $69.62 | $219,859.01 |
DisclosureSEC source: 0001567619-18-007116 · doc1.xml · nonDerivative · entry 8 Bailey Sue · CIK 0001403769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,972 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.50 to $70.05, inclusive. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 16:41 UTC |
Bailey SueDirector
|
Exercise / conversionCommon Stock | 3,158 | $13.37 | $42,222.46 |
DisclosureSEC source: 0001567619-18-007116 · doc1.xml · nonDerivative · entry 7 Bailey Sue · CIK 0001403769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 16:41 UTC |
Bailey SueDirector
|
SaleCommon Stock | 4,736 | $69.62 | $329,718.90 |
DisclosureSEC source: 0001567619-18-007116 · doc1.xml · nonDerivative · entry 6 Bailey Sue · CIK 0001403769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,972 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.50 to $70.05, inclusive. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 16:41 UTC |
Bailey SueDirector
|
Exercise / conversionCommon Stock | 4,736 | $13.00 | $61,568.00 |
DisclosureSEC source: 0001567619-18-007116 · doc1.xml · nonDerivative · entry 5 Bailey Sue · CIK 0001403769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 16:41 UTC |
Bailey SueDirector
|
SaleCommon Stock | 1,579 | $69.62 | $109,929.51 |
DisclosureSEC source: 0001567619-18-007116 · doc1.xml · nonDerivative · entry 4 Bailey Sue · CIK 0001403769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,972 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.50 to $70.05, inclusive. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 16:41 UTC |
Bailey SueDirector
|
Exercise / conversionCommon Stock | 1,579 | $20.08 | $31,706.32 |
DisclosureSEC source: 0001567619-18-007116 · doc1.xml · nonDerivative · entry 3 Bailey Sue · CIK 0001403769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 16:41 UTC |
Bailey SueDirector
|
SaleCommon Stock | 8,244 | $69.62 | $573,944.81 |
DisclosureSEC source: 0001567619-18-007116 · doc1.xml · nonDerivative · entry 2 Bailey Sue · CIK 0001403769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,972 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.50 to $70.05, inclusive. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 16:41 UTC |
Bailey SueDirector
|
Exercise / conversionCommon Stock | 8,244 | $18.64 | $153,668.16 |
DisclosureSEC source: 0001567619-18-007116 · doc1.xml · nonDerivative · entry 1 Bailey Sue · CIK 0001403769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2018 Filed Feb 21, 2019 00:48 UTC Amendment |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 20,832 | $0.00 Strike: $13.38 | $0.00 |
DisclosureSEC source: 0000899243-19-004317 · doc4a.xml · derivative · entry 9 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,832 shares Expires 2020-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on June 6, 2018 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F4 · kind: The reported option exercises were inadvertently omitted from the original Form 4 filed with the SEC on November 28, 2018, which reported the sales of shares of Common Stock only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises. F7 · derivative.exercise_date: The options vested in three equal installments on March 11, 2014, March 11, 2015 and March 11, 2016. Read SEC document |
| November 27, 2018 Filed Feb 21, 2019 00:48 UTC Amendment |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 20,832 | $69.59 | $1,449,698.88 |
DisclosureSEC source: 0000899243-19-004317 · doc4a.xml · nonDerivative · entry 5 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,488,675 F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on June 6, 2018 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F5 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.31 to $70.32. Read SEC document |
| November 27, 2018 Filed Feb 21, 2019 00:48 UTC Amendment |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionCommon Stock | 20,832 | $13.38 | $278,732.16 |
DisclosureSEC source: 0000899243-19-004317 · doc4a.xml · nonDerivative · entry 4 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,509,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on June 6, 2018 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F4 · kind: The reported option exercises were inadvertently omitted from the original Form 4 filed with the SEC on November 28, 2018, which reported the sales of shares of Common Stock only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises. F3 · balance_after: The number of shares of Common Stock directly beneficially owned by the Reporting Person reported on this amended Form 4 gives effect to the sales of Common Stock by the Reporting Person as reported on the Forms 4 filed with the SEC on November 21, 2018 and November 28, 2018, as applicable. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 22:48 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 25,000 | $69.96 | $1,749,000.00 |
DisclosureSEC source: 0000899243-18-029754 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428,502 F1 · kind: All sales listed on this Form 4 were made by Mr. El-Hibri pursuant to a trading plan adopted on June 6, 2018 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934 (the "Exchange Act"). F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.98 to $71.76. Read SEC document |
| November 26, 2018 Filed Feb 21, 2019 00:48 UTC Amendment |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $13.38 | $0.00 |
DisclosureSEC source: 0000899243-19-004317 · doc4a.xml · derivative · entry 8 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,832 Underlying: Common Stock · 25,000 shares Expires 2020-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on June 6, 2018 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F4 · kind: The reported option exercises were inadvertently omitted from the original Form 4 filed with the SEC on November 28, 2018, which reported the sales of shares of Common Stock only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises. F7 · derivative.exercise_date: The options vested in three equal installments on March 11, 2014, March 11, 2015 and March 11, 2016. Read SEC document |
| November 26, 2018 Filed Feb 21, 2019 00:48 UTC Amendment |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionCommon Stock | 25,000 | $13.38 | $334,500.00 |
DisclosureSEC source: 0000899243-19-004317 · doc4a.xml · nonDerivative · entry 3 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,513,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on June 6, 2018 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F4 · kind: The reported option exercises were inadvertently omitted from the original Form 4 filed with the SEC on November 28, 2018, which reported the sales of shares of Common Stock only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises. F3 · balance_after: The number of shares of Common Stock directly beneficially owned by the Reporting Person reported on this amended Form 4 gives effect to the sales of Common Stock by the Reporting Person as reported on the Forms 4 filed with the SEC on November 21, 2018 and November 28, 2018, as applicable. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 21:15 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 15,173 | $70.03 | $1,062,565.19 |
DisclosureSEC source: 0000899243-18-029546 · doc4.xml · nonDerivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,453,502 F1 · kind: All sales listed on this Form 4 were made by Mr. El-Hibri pursuant to a trading plan adopted on June 6, 2018 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934 (the "Exchange Act"). F3 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.67 to $71.18. Read SEC document |
| November 20, 2018 Filed Feb 21, 2019 00:48 UTC Amendment |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 15,173 | $0.00 Strike: $14.44 | $0.00 |
DisclosureSEC source: 0000899243-19-004317 · doc4a.xml · derivative · entry 7 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,173 shares Expires 2019-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on June 6, 2018 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F2 · kind: The reported option exercises were inadvertently omitted from the original Form 4 filed with the Securities and Exchange Commission ("SEC") on November 21, 2018, which reported the sales of shares of the Issuer's common stock ("Common Stock") only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises. F6 · derivative.exercise_date: The options vested in three equal installments on March 12, 2013, March 12, 2014 and March 12, 2015. Read SEC document |
| November 20, 2018 Filed Feb 21, 2019 00:48 UTC Amendment |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionCommon Stock | 15,173 | $14.44 | $219,098.12 |
DisclosureSEC source: 0000899243-19-004317 · doc4a.xml · nonDerivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,503,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on June 6, 2018 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F2 · kind: The reported option exercises were inadvertently omitted from the original Form 4 filed with the Securities and Exchange Commission ("SEC") on November 21, 2018, which reported the sales of shares of the Issuer's common stock ("Common Stock") only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises. F3 · balance_after: The number of shares of Common Stock directly beneficially owned by the Reporting Person reported on this amended Form 4 gives effect to the sales of Common Stock by the Reporting Person as reported on the Forms 4 filed with the SEC on November 21, 2018 and November 28, 2018, as applicable. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:15 UTC |
El-Hibri FuadDirector · Chairman · 10% owner
|
SaleCommon Stock | 20,000 | $69.54 | $1,390,800.00 |
DisclosureSEC source: 0000899243-18-029546 · doc4.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,468,675 F1 · kind: All sales listed on this Form 4 were made by Mr. El-Hibri pursuant to a trading plan adopted on June 6, 2018 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934 (the "Exchange Act"). F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.51 to $71.27. Read SEC document |
| November 19, 2018 Filed Feb 21, 2019 00:48 UTC Amendment |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $14.44 | $0.00 |
DisclosureSEC source: 0000899243-19-004317 · doc4a.xml · derivative · entry 6 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,173 Underlying: Common Stock · 20,000 shares Expires 2019-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on June 6, 2018 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F2 · kind: The reported option exercises were inadvertently omitted from the original Form 4 filed with the Securities and Exchange Commission ("SEC") on November 21, 2018, which reported the sales of shares of the Issuer's common stock ("Common Stock") only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises. F6 · derivative.exercise_date: The options vested in three equal installments on March 12, 2013, March 12, 2014 and March 12, 2015. Read SEC document |
| November 19, 2018 Filed Feb 21, 2019 00:48 UTC Amendment |
El-Hibri FuadDirector · Chairman · 10% owner
|
Exercise / conversionCommon Stock | 20,000 | $14.44 | $288,800.00 |
DisclosureSEC source: 0000899243-19-004317 · doc4a.xml · nonDerivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,508,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on June 6, 2018 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F2 · kind: The reported option exercises were inadvertently omitted from the original Form 4 filed with the Securities and Exchange Commission ("SEC") on November 21, 2018, which reported the sales of shares of the Issuer's common stock ("Common Stock") only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 23:49 UTC |
Zoon Kathryn CDirector
|
SaleCommon Stock | 1,871 | $70.08 | $131,117.62 |
DisclosureSEC source: 0001567619-18-005458 · doc1.xml · nonDerivative · entry 2 Zoon Kathryn C · CIK 0001685720 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,643 F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.05 to $70.18, inclusive. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 23:49 UTC |
Zoon Kathryn CDirector
|
SaleCommon Stock | 2,371 | $69.48 | $164,738.03 |
DisclosureSEC source: 0001567619-18-005458 · doc1.xml · nonDerivative · entry 1 Zoon Kathryn C · CIK 0001685720 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,514 F1 · shares: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Zoon. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.90 to $70.14, inclusive. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 22:14 UTC |
Richard RonaldDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,893 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0001567619-18-005447 · doc1.xml · derivative · entry 3 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Comon Stock · 7,893 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard. F3 · derivative.exercise_date: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 22:14 UTC |
Richard RonaldDirector
|
SaleCommon Stock | 7,893 | $70.00 | $552,510.00 |
DisclosureSEC source: 0001567619-18-005447 · doc1.xml · nonDerivative · entry 2 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,963 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.